Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) Associated With Highly Emetogenic Chemotherapy (0869-801)(COMPLETED)

NCT00090207 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

477

Enrollment

INDUSTRY

Sponsor class

Conditions

Nausea
Vomiting

Interventions

DRUG: MK0869, aprepitant / Duration of Treatment: 3 days
DRUG: Comparator: ondansetron / Duration of Treatment: 4 days

Sponsor

Merck Sharp & Dohme LLC